Directori de persones
Carolina Lopez Cano

Carolina Lopez Cano

Grau: Doctor/a


clopezc(ELIMINAR)@gss.cat

Publicacions

  • Gutiérrez-Carrasquilla L; Sánchez E; Hernández M; Polanco D; Salas-Salvadó J; Betriu À; Gaeta AM; Carmona P; Purroy F; Pamplona R; Farràs C; López-Cano C; Fernández E; Lecube A

    Effects of Mediterranean Diet and Physical Activity on Pulmonary Function: A Cross-Sectional Analysis in the ILERVAS Project

    Nutrients 11 -. .

    [doi:10.3390/nu11020329]

  • Rius, F; Sanchez, E; Betriu À; Baena-Fustegueras, JA; Yeramian, A; Vidal, T; Hernandez, M; Lopez-Cano, C; Bueno, M; Gutierrez-Carrasquilla, L; Herrerias, F; de la Fuente, MC; Fernandez, E; Lecube, A

    Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal

    OBESITY SURGERY 28 3935-3942. .

    [doi:10.1007/s11695-018-3410-x]

  • Lecube, A.; Sanchez, E.; Lopez-Cano, C.; Sanchez, M.; Gaeta, A.; Purroy, F.; Pamplona, R.; Ortega, M.; Vidal, T.; Betriu, A.; Gomez, X.; Hernandez, M.; Olsina, J.; Hernandez, C.; Simo, R.

    Pulmonary function in prediabetes: dysfunction appears before the development of type 2 diabetes

    Diabetologia 61 512-512. .

  • Hernandez, M; Lopez, C; Soldevila, B; Cecenarro, L; Martinez-Barahona, M; Palomera, E; Rius, F; Lecube, A; Pelegay, MJ; Garcia, J; Mauricio, D; Puig Domingo, Manel

    Impact of TSH during the first trimester of pregnancy on obstetric and foetal complications: Usefulness of 2.5 mIU/L cut-off value

    CLINICAL ENDOCRINOLOGY 88 728-734. .

    [doi:10.1111/cen.13575]

  • Lecube A.; Carolina L.-C.

    Regulation of food intake

    Encyclopedia Of Endocrine Diseases 363-369. .

    [doi:10.1016/B978-0-12-801238-3.66204-9]

  • Lecube, A; Simo, R; Pallayova, M; Punjabi, NM; Lopez-Cano, C; Turino, C; Hernandez, C; Barbe, F

    Pulmonary Function and Sleep Breathing: Two New Targets for Type 2 Diabetes Care

    Endocrine Reviews 38 550-573. .

    [doi:10.1210/er.2017-00173]

  • Lopez-Cano, C; Lecube, A; Garcia-Ramirez, M; Muñoz X; Sanchez, E; Seminario, A; Hernandez, M; Ciudin, A; Gutierrez, L; Hernandez, C; Simo, R

    Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 102 4109-4116. .

    [doi:10.1210/jc.2017-00913]

  • Lecube, A.; Sanchez, E.; Betriu, A.; Gutierrez-Carrasquilla, L.; Elias, M.; Barbe, F.; Purroy, F.; Buti, M.; Fernandez, E.; Lopez-Cano, C.

    Impaired pulmonary function in type 2 diabetes: Is there a role for advanced glycation end-products measured by skin autofluorescence?Data form the ILERVAS project

    Diabetologia 60 503-503. .

  • Hernandez, M; Lopez, C; Real, J; Valls, J; Ortega-Martinez de Victoria E; Vazquez, F; Rubinat, E; Granado-Casas, M; Alonso, N; Moli, T; Betriu, A; Lecube, A; Fernandez, E; Leslie, RD; Mauricio, D

    Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

    Cardiovascular Diabetology 16 94-94. .

    [doi:10.1186/s12933-017-0576-9]

  • Ridker PM; Revkin J; Amarenco P; Brunell R; Curto M; Civeira F; Flather M; Glynn RJ; Gregoire J; Jukema JW; Karpov Y; Kastelein JJP; Koenig W; Lorenzatti A; Manga P; Masiukiewicz U; Miller M; Mosterd A; Murin J; Nicolau JC; Nissen S; Ponikowski P; Santos RD; Schwartz PF; Soran H; White H; Wright RS; Vrablik M; Yunis C; Shear CL; Tardif JC; SPIRE Cardiovascular Outcome Investigators

    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

    NEW ENGLAND JOURNAL OF MEDICINE 376 1527-1539. .

    [doi:10.1056/NEJMoa1701488]

  • Lecube, A; Sanchez, E; Lopez-Cano, C; Hernandez, C; Simo, R

    Type 2 diabetes, risk of sleep apnea-hypopnea syndrome, and quality of life associated to sleep breathing disorders Diabetes

    Endocrinologia, diabetes y nutricion 64 174-176. .

    [doi:10.1016/j.endinu.2016.10.009]

  • Sanchez, E; Betriu À; Arroyo, D; Lopez, C; Hernandez, M; Rius, F; Fernandez, E; Lecube, A

    Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study

    PLOS ONE 12 -. .

    [doi:10.1371/journal.pone.0170778]

Projectes

  • Unraveling the role of piwi-interacting RNAs in the pathogenesis of obesity-induced kidney disease. Identification of potential biomarkers and therapeutic targets (RENOPIWI)
  • SUSCEPTIBILIDAD GENÉTICA PARA PREDECIR LA PÉRDIDA DE PESO TRAS LA CIRUGÍA BARIÁTRICA
  • El efecto de la diabetes mellitus tipo 2 y la obesidad sobre la cronodisrupción. La hipoxia nocturna como nexo de unión.
  • ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
  • Impacte dels trastorns de la respiració nocturna en les característiques i evolució de les úlceres del peu en pacients amb diabetis (Estudi PEU)
  • Impacto de la composición corporal en la prevalencia, gravedad, propagación y pérdida de inmunidad en la infección por COVID-19
  • La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)